Industry Symposia

Please join us to our Alcon Vit-Ret Surgical Symposium. A selected panel of experienced surgeons will present our latest innovations through video cases and will be available for a live Q&A session.

  • Sharkskin cases
    Jean-Antoine Pournaras (Switzerland)
  • Beveled cutter cases
    Khalid Al Sabti (Kuwait)
  • Ngenuity in VR
    Hasan Mortada (Egypt)

Please join us to our Alcon Cataract Surgical Symposium. A selected panel of experienced surgeons will present our latest innovations in 3D visualization, Preloaded IOLs, Phaco technologies and will be available for a live Q&A session.

  • Benefits of utilizing a 3D visualization system for cataract surgery
    Brian Armstrong (USA)
  • Minimally Invasive Cataract Surgery with Centurion Active Sentr
    Nic Reus (Netherlands)
  • Modern preloaded IOL device with Clareon AutonoMe
    Andrew Ivey (South Africa)

Please join us to our Alcon PC-IOL and Refractive Surgical Symposium. A selected panel of experienced surgeons will present our latest innovations on presbyopia correcting IOLs, Laser vision correction and will be available for a live Q&A session

  • Patient selection as key driver to succeed on PC IOLs
    Ahmet Akman (Turkey)
  • A new wavefront technology
    Francesco Carones (Italy)
  • Early experience with InnovEyes
    A. John Kanellopoulos (Greece)

Discover the results of the Kodjikian meta-analysis, evaluating the efficacy of anti-VEGF and dexamethasone (DEX) implants for DME within real-world observational studies1. Learn how DEX can help deliver a real-world difference for your suitable patients with an analysis of real-life injection intervals and follow-ups in a varied patient pool.

1. Kodjikian L et al. Biomed Res Int 2018:8289253

The Indian-based ophthalmic drug maker ENTOD Pharmaceuticals has recently introduced PHENOCAINE PLUS – a preservative free & terminally sterilized intracameral injection containing a combination of mydriatics and anaesthetic at optimized doses. PHENOCAINE PLUS requires no refrigeration and is injected during cataract surgery to achieve rapid & stable pupillary dilatation without the need for preoperative dilating eye drops, and for sustained intraocular anaesthesia for pain-free surgery & better surgical outcomes. This video symposium demonstrates the use of Phenocaine Plus in Cataract Surgery and introduces the concept of Phenocaine Assisted Cataract Surgery (PACS).

  • Gaurav Luthra (India)

For many years, subjective refraction techniques have not really changed. With the introduction of a new phoropter using continuous power changes, a new approach of refraction is now possible. In this presentation, the benefits offered by this new technology will be described and a new subjective refraction method, using a vectorial technique, will be presented. The presentation will also show how the determination of refraction can be made, at the same time, more accurate and easier to perform for the practitioner as well as more comfortable for the patient.

  • Dominique Meslin (France)

Descemet Membrane Endothelial Keratoplasty (DMEK) is one of the fastest-growing techniques for treating corneal disease. This virtual wet lab will include a presentation on Eversight tissue preparation, live commentary of an insertion technique demonstration on a Barron Artificial Anterior Chamber, and live commentary of a DMEK surgery. Attendees will gain the insight needed to integrate innovative DMEK surgery into their practice. This Eversight virtual wet lab will run one hour and conclude with a live Q&A session.

  • David Chu (USA)
  • Erik Hellier (USA)

Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) offers the advantage of relatively rapid healing time and visual rehabilitation. This virtual wet lab will include a presentation on Eversight tissue preparation, live commentary of an insertion technique demonstration on a Barron Artificial Anterior Chamber, and live commentary of a DSAEK surgery. Attendees will gain the insight needed to integrate DSAEK surgery into practice. This Eversight virtual wet lab will run one hour and conclude with a live Q&A session.

  • Elmer Tu (USA)
  • Erik Hellier (USA)

Dr. Shin Yamane (Japan) explains the advantages of his flanged intrascleral intraocular IOL fixation technique employing the Geuder double needle stabilizer to assure that the intrascleral tunnels are precisely equal in length with 20° angulation and 10° tilt and that sclerotomy entry occurs in the right places, 180° apart. Control over the insertion angles allows for intraoperative adjustment of the refractive error with accuracy of up to 0.5 diopters.

  • Shin Yamane (Japan)

Dr. Sergio Jacobovitz (Brazil) explains why pre-chopping with a forward movement employing a front blade chopper is more efficient and safer than pre-chopping with a conventional chopper that cuts with a backward movement due to its rear blade design. He further explains the multifunctional chopper’s versatile chopping, cracking and retracting functions reducing the number of required instruments and movements within the anterior segment suitable for all grades of cataracts

  • Sergio Jacobovitz (Brazil)

This Webinar will introduce imaging in post-COVID life and gives a structured insight in the application of modern high-tech multimodal imaging using the ANTERION and SPECTRALIS All-in one devices.

  • All-in-one Multimodal Imaging device ANTERION
    Rohit Shetty (India)
  • ANTERION cases
    Pooja Khamar (India)
  • All-in-one Multimodal Imaging device SPECTRALIS and cases
    Chaitra Jayadev (India)

Our recent introduction, Mirante, is a multimodal SLO/OCT platform with Ultra-Widefield imaging capabilities that is considered the gold standard in the field. Dr. Sadda will present advanced discoveries on drusen by multimodal imaging along with Retro mode, improving the ability to phenotype and diagnose disease.

  • SriniVas Sadda (USA)

We offer products that allow clinicians to maintain physical distancing yet improve patient flow and clinic efficiency. Dr. Daya will present on how clinicians can ensure staff and patient safety by reducing institutional risks with NIDEK products during the COVID-19 pandemic.

  • Sheraz M. Daya (UK)

This symposium will examine the current real-world challenges with nAMD under-treatment, and explore how new treatment paradigms, offering greater durability and better disease control, could potentially help improve the care provided to patients. The panel of international retinal specialists will discuss evidence-based treatment decisions during their presentations and the interactive Q&A session.

Chair(s): Anat Loewenstein (Israel)

  • Under-treatment in nAMD: the persistent gap between clinical trials and the real-world​
    Ramin Khoramnia (Germany)
  • Developments in the nAMD treatment landscape
    Peter Kaiser (USA)
  • Brolucizumab Clinical Program Update: Efficacy and Safety​
    Anat Loewenstein (Israel)

Gene therapy is one of the most rapidly evolving areas of medicine. As we move forward into this new therapeutic era, it is important to prepare for the eventual introduction of gene therapies into the retinal treatment landscape, in the years to come.
This symposium will introduce the variety of approaches to retinal gene therapy, and explore some of the most recent innovations and ongoing studies within ophthalmology, including inherited retinal dystrophies (IRDs). A panel of experts will discuss the importance of early and accurate genetic testing and counselling, to understand the unique strategies and challenges involved in the diagnosis and management of patients with IRDs.

Chair(s): Raj Ramesar (South Africa)

  • Emmerging trends in retinal gene therapy
    Mark Pennesi (USA)
  • Challenges along the IRD diagnosis journey: a patient perspective
    Claudette Medefindt (South Africa)
  • Learnings from South Africa: identifying causative genes for IRDs
    Raj Ramesar (South Africa)
  • Inherited retinal dystrophies (IRDs): patient identification in clinical practice
    Juliana Sallum (Brazil)
  • From diagnosis to treatment: ocular gene therapy in the real world
    Selwa Al-Hazzaa (Saudi Arabia)

This symposium will explore the significant contribution made by ranibizumab to treating retinal diseases across all age groups, helping to reduce the burden of global blindness. Our panel of four of the world’s leading retinal specialists will share their thoughts on treating patients across the various approved retinal disease indications. Results from recent clinical studies will inform the discussion on how ranibizumab treatment strategies can be optimized to elicit the best possible outcomes for patients of all ages. Please join us for an informative and stimulating meeting.

Chair(s): Jennifer Arnold (Australia)

  • Clinical value of treat & extend regimen in nAMD
    Ramin Tadayoni (France)
  • Management of diabetic retinopathy: current treatment perspectives
    Patricio Schlottmann (Argentina)
  • The changing clinical paradigm in retinopathy of prematurity
    Maria Ana Martinez Castellanos (Mexico)

Dr Auffarth opens the symposium and asks whether the new Pentacam® AXL Wave is worth the investment. He explains the new hardware, features the applications, shows the new measuring process which he calls “fool proof” and explains how the device is used in his clinic.
With the help of various software screens, Dr Savini shows how he uses the Pentacam® AXL Wave – also for patient education – and shares interesting cases. He also gives insights on his studies on IOL formulas.

  • Gerd U. Auffarth (Germany)
  • Giacomo Savini (Italy)

Please join Prof. Armin Wolf (Germany) for the latest updates in modern cataract surgery. He will make you understand how clever physics and fluidics support your modern cataract surgery and could bring more safety and efficiency into your OR.

  • Armin Wolf (Germany)

Robin is dedicated to provide digital solutions assisting with the diagnosis of medical images, based on our core competence in Artificial Intelligence (AI) with Deep Learning (DL) algorithms which enable medical experts to ease their daily work to reach better results more efficiently. robin solutions can be easily integrated into existing IT infrastructures and databases.
The recently launched Robin Endothelium Analyzer REA XDL is an AI based solution which is a specialised system to qualify donor corneas processed in eye banks. REA XDL sets a new benchmark in endothelium cell analysation. Experts benefit from REA XDL due to its accuracy, versatility and efficiency.

  • Georg H. Langstrof (Germany)

Instructional video symposium on lens based refractive surgery and how to get the best possible patient experience out of state-of-the-art IOL technology

  • Enhanced depth of focus = NEW standard of care over monofocal
    Detlev Breyer (Germany)
  • Functional vision – What compromise must we make
    Patrick Versace (Australia)